Hiroaki Matsuoka

Q: What Schools Are Affiliated With Hiroaki Matsuoka

Hiroaki Matsuoka is affiliated with the following schools: University of Tokyo, Dokkyo Medical University, Dokkyo University

Hiroaki Matsuoka's AcademicInfluence.com Rankings

Hiroaki Matsuoka

Philosophy

#9406

World Rank

#12960

Historical Rank

Logic

#6386

World Rank

#7898

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Hiroaki Matsuoka's Degrees

Doctorate Medicine Kyoto University
PhD Medicine Kyoto University

Why Is Hiroaki Matsuoka Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hiroaki Matsuoka's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) (2009) (1116)
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. (1994) (476)
The role of natriuretic peptides in cardioprotection. (2006) (449)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2 (2009) (365)
Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study (2010) (326)
Increased plasma levels of adrenomedullin in patients with heart failure. (1995) (308)
Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control (2006) (287)
Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. (1996) (277)
Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. (2003) (241)
Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. (1999) (241)
Genomic structure of human adrenomedullin gene. (1994) (204)
The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension (2009) (199)
[Masked hypertension]. (2014) (196)
Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. (1998) (196)
Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients (2009) (171)
Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. (1998) (171)
Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. (2000) (156)
The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): Protocol, Patient Characteristics, and Blood Pressure during the First 12 Months (2005) (131)
Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. (2006) (127)
Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts. (2002) (127)
Cardioprotective Mechanisms of Eplerenone on Cardiac Performance and Remodeling in Failing Rat Hearts (2006) (114)
Role of systolic blood pressure in determining prognosis of hemodialyzed patients. (1995) (109)
Endothelin: a new inhibitor of renin release. (1988) (109)
Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. (2001) (107)
Biphasic effects of repeated alcohol intake on 24-hour blood pressure in hypertensive patients. (1994) (105)
Angiotensin II and Oxidative Stress in Dahl Salt-Sensitive Rat With Heart Failure (2002) (105)
Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. (2008) (98)
Eplerenone Shows Renoprotective Effect by Reducing LOX-1–Mediated Adhesion Molecule, PKC&egr;-MAPK-p90RSK, and Rho-Kinase Pathway (2005) (98)
Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. (1993) (97)
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial (2011) (95)
Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats (2004) (94)
Inhibition of aldosterone production by alpha-human atrial natriuretic polypeptide is associated with an increase in cGMP production. (1985) (91)
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. (2007) (87)
Plasma concentrations of α-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease (1987) (86)
Elevated plasma catecholamines in hypertensives with primary glomerular diseases. (1983) (86)
Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure. (1998) (85)
Renoprotective Effect of Chronic Adrenomedullin Infusion in Dahl Salt-Sensitive Rats (2002) (85)
Globular Adiponectin Activates Nuclear Factor-κB and Activating Protein-1 and Enhances Angiotensin II–Induced Proliferation in Cardiac Fibroblasts (2007) (84)
Celiprolol Activates eNOS Through the PI3K-Akt Pathway and Inhibits VCAM-1 Via NF-&kgr;B Induced by Oxidative Stress (2003) (83)
Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. (1999) (82)
The effects of human atrial 28-amino acid peptide on systemic and renal hemodynamics in anesthetized rats. (1985) (79)
Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. (1992) (76)
Beta-lipotropin: a new aldosterone-stimulating factor. (1980) (75)
Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension (2002) (73)
Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats. (2002) (71)
Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients <20 years of age. (1997) (69)
Renal Arterioiar Diameters in Spontaneously Hypertensive Rats Vascular Cast Study (1991) (68)
Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure. (2002) (67)
A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension--The GLANT Study. Study Group on Long-term Antihypertensive Therapy. (1995) (66)
Comparison of Atherosclerotic Indicators Between Cardio Ankle Vascular Index and Brachial Ankle Pulse Wave Velocity (2009) (64)
Cardioprotective effect of adrenomedullin in heart failure. (2003) (62)
Cardioprotective Mechanisms of Spironolactone Associated with the Angiotensin-Converting Enzyme/Epidermal Growth Factor Receptor/Extracellular Signal-Regulated Kinases, NAD(P)H Oxidase/Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, and Rho-Kinase Pathways in Aldosterone/Salt-Induced Hypert (2005) (61)
Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis (1997) (61)
Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR. (1999) (59)
Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells. (1998) (57)
Renal Vasoconstriction by the Endothelial Cell-Derived Peptide Endothelin in Spontaneously Hypertensive Rats (1989) (56)
Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension (2009) (56)
The Optimal Target Blood Pressure for Antihypertensive Treatment in Japanese Elderly Patients with High-Risk Hypertension: A Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial (2008) (55)
Effects of β-Lipotropin and β-Lipotropin-derived Peptides on Aldosterone Production in the Rat Adrenal Gland (1981) (54)
Chronic Administration of Adrenomedullin Attenuates Transition From Left Ventricular Hypertrophy to Heart Failure in Rats (2003) (53)
Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard. (1998) (53)
Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats. (1991) (51)
Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats (2005) (51)
Effects of amlodipine on nitric oxide synthase mRNA expression and coronary microcirculation in prolonged nitric oxide blockade-induced hypertensive rats. (1999) (51)
Antioxidative effect of p38 mitogen-activated protein kinase inhibitor in the kidney of hypertensive rat (2005) (50)
Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats. (1999) (50)
The Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial: Rationale and Design (2005) (49)
Long-Term Administration of Rho-Kinase Inhibitor Ameliorates Renal Damage in Malignant Hypertensive Rats (2006) (47)
Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats. (1996) (47)
Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. (1994) (47)
The association between salt sensitivity of blood pressure and some polymorphic factors (1994) (46)
Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects. (1997) (46)
Increased release of atrial natriuretic polypeptides in rats with DOCA-salt hypertension. (1986) (46)
Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis. (2006) (45)
Production and clearance sites of two molecular forms of adrenomedullin in human plasma. (2000) (44)
Role of Endogenous Atrial Natriuretic Peptide in DOCA‐Salt Hypertensive Rats Effects of a Novel Nonpeptide Antagonist for Atrial Natriuretic Peptide Receptor (1993) (43)
EFFECTS OF AMLODIPINE AND NIFEDIPINE RETARD ON AUTONOMIC NERVE ACTIVITY IN HYPERTENSIVE PATIENTS (1998) (43)
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial1 (2014) (43)
Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats (2007) (43)
Plasma levels of adrenomedullin in patients with acute myocardial infarction. (1998) (43)
Efonidipine Reduces Proteinuria and Plasma Aldosterone in Patients with Chronic Glomerulonephritis (2007) (43)
Ventricular Adrenomedullin System in the Transition From LVH to Heart Failure in Rats (2003) (42)
Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy. (2006) (41)
Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension. (1996) (41)
Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure. (2005) (41)
Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/Gi pathways in rat cultured adipocytes (2009) (41)
Effects of prostaglandins on adrenal steroidogenesis in the rat. (1980) (40)
Inhibitory effect of endothelin on renin release in vitro. (1989) (40)
Long-Term Adrenomedullin Infusion Improves Survival in Malignant Hypertensive Rats (2002) (40)
Acute effects of alcohol ingestion on blood pressure and erythrocyte sodium concentration (1993) (40)
Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats (2001) (40)
Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice (2009) (40)
Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney. (1996) (40)
Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. (2000) (38)
Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition. (2006) (38)
Comparison of changes in cardiac structure after treatment in secondary hypertension. (1996) (38)
Effects of Manidipine Hydrochloride on the Renal Microcirculation in Spontaneously Hypertensive Rats (1992) (38)
Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. (2000) (38)
Regulatory effect of thromboxane A2 on proliferation of vascular smooth muscle cells from rats. (1991) (37)
valsartan in elderly isolated systolic hypertension (VALISH) study: rationale and design. (2004) (37)
Nicorandil Enhances Cardiac Endothelial Nitric Oxide Synthase Expression via Activation of Adenosine Triphosphate‐Sensitive K Channel in Rat (2001) (36)
Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA. (2000) (36)
Radical Scavengers of Indapamide in Prostacyclin Synthesis in Rat Smooth Muscle Cell (1990) (36)
Effects of cilnidipine on nitric oxide and endothelin-1 expression and extracellular signal-regulated kinase in hypertensive rats. (2001) (34)
Effects of long-term intravenous administration of adrenomedullin (AM) plus hANP therapy in acute decompensated heart failure: a pilot study. (2009) (34)
Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function. (2004) (34)
On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension (2017) (33)
Benidipine inhibits expression of ET-1 and TGF-beta1 in Dahl salt-sensitive hypertensive rats. (2001) (33)
Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients. (1998) (33)
Behaviour of adrenomedullin during acute and chronic salt loading in normotensive and hypertensive subjects. (1996) (33)
Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure (2001) (33)
Antihypertensive Efficacy and Safety of Fixed-Dose Combination Therapy with Losartan plus Hydrochlorothiazide in Japanese Patients with Essential Hypertension (2007) (33)
[Guidelines on Treatment of Hypertension in the Elderly--2002 Revised Version]. (2002) (33)
Role of serotonin type 2 receptors in regulation of aldosterone production. (1985) (32)
TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats. (2001) (32)
Edaravone Prevented Deteriorated Cardiac Function After Myocardial Ischemia-Reperfusion via Inhibiting Lipid Peroxidation in Rat (2005) (32)
Different effects of alcohol and salt on 24-hour blood pressure and heart rate in hypertensive patients. (1996) (32)
EFFECT OF EXERCISE ON PLASMA ADRENOMEDULLIN AND NATRIURETIC PEPTIDE LEVELS IN MYOCARDIAL INFARCTION (1997) (32)
High Accumulation of Endothelial Nitric Oxide Synthase (ecNOS):A Gene Polymorphism in Patients with End-Stage Renal Disease (1998) (32)
Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial (2012) (32)
Nicorandil Protects Against Lethal Ischemic Ventricular Arrhythmias and Up-regulates Endothelial Nitric Oxide Synthase Expression and Sulfonylurea Receptor 2 mRNA in Conscious Rats with Acute Myocardial Infarction (2004) (32)
Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats (2008) (31)
Difference in the incidence of cough induced by angiotensin converting enzyme inhibitors: a comparative study using imidapril hydrochloride and enalapril maleate. (1999) (31)
Effect of benidipine on microvascular remodeling and coronary flow reserve in two‐kidney, one clip Goldblatt hypertension (1997) (31)
Microsatellite DNA Polymorphism of Human Adrenomedullin Gene in Normotensive Subjects and Patients With Essential Hypertension (2001) (30)
Role of Endogenous Atrial Natriuretic Peptide in Regulating Sodium Excretion in Spontaneously Hypertensive Rats: Effects of Neutral Endopeptidase Inhibition (1991) (30)
Effects of alcohol intake on ambulatory blood pressure, heart rate, and heart rate variability in Japanese men with different ALDH2 genotypes (2002) (30)
Activation of AMP-Activated Protein Kinase Enhances Angiotensin II–Induced Proliferation in Cardiac Fibroblasts (2006) (30)
Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction (2010) (29)
Multiple left ventricular diverticula detected by second harmonic imaging: a case report. (2003) (29)
Protective Effects of an Angiotensin II Receptor Blocker and a Long-Acting Calcium Channel Blocker against Cardiovascular Organ Injuries in Hypertensive Patients (2005) (29)
Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene. (2005) (29)
Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes. (2008) (28)
Effects of Imidapril on Left Ventricular Mass in Chronic Hemodialysis Patients (2006) (28)
Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats. (2000) (28)
Interferon Gamma Attenuates Hypertensive Renal Injury in Salt‐Sensitive Dahl Rats (1992) (28)
Imidapril improves l-NAME-exacerbated nephrosclerosis with TGF-β1 inhibition in spontaneously hypertensive rats (2004) (28)
Stimulation of aldosterone production by β-melanotropin (1981) (28)
Effects of sairei-to on the relapse of steroid-dependent nephrotic syndrome. (1990) (27)
Elevation of two molecular forms of adrenomedullin in plasma and urine in patients with acute myocardial infarction treated with early coronary angioplasty. (2001) (27)
Left ventricular mass relates to average systolic blood pressure, but not loss of circadian blood pressure in stable hemodialysis patients: an ambulatory 48-hour blood pressure study. (2001) (27)
Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats (2002) (27)
Guidelines for treatment of hypertension in the elderly--2002 revised version. (2003) (26)
Calcium supplementation in patients with essential hypertension: Assessment by office, home and ambulatory blood pressure (1998) (26)
The Work-Hardening Process in Metals (1969) (26)
Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial (2014) (26)
Effects of alcohol restriction on ambulatory blood pressure, heart rate, and heart rate variability in Japanese men. (2002) (26)
Guidelines for Hypertension in the Elderly (1999) (26)
Urinary excretion of liver fatty acid-binding protein in health-check participants (2005) (25)
Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats. (2008) (25)
Role of increased circulating and renal adrenomedullin in rats with malignant hypertension. (2001) (25)
Relationship between birth weight and cardiovascular risk factors in Japanese young adults. (1999) (25)
Radical Scavenging Properties of Indapamide and Renal Protection in Dahl Salt-Sensitive Rats (1992) (25)
Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial (2013) (25)
Cardioprotective effects of pitavastatin on cardiac performance and remodeling in failing rat hearts. (2009) (25)
Effects of repeated alcohol intake on blood pressure and sodium balance in Japanese males with hypertension. (2004) (24)
Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension. (2004) (24)
Relation between the angiotensin-converting enzyme insertion/deletion polymorphism and blood pressure in Japanese male subjects (2003) (24)
Comparison of the Antialbuminuric Effects of L-/N-type and L-type Calcium Channel Blockers in Hypertensive Patients with Diabetes and Microalbuminuria: The Study of Assessment for Kidney Function by Urinary Microalbumin in Randomized (SAKURA) Trial (2013) (24)
Comparison of Efficacy and Safety Between Bisoprolol Transdermal Patch (TY‐0201) and Bisoprolol Fumarate Oral Formulation in Japanese Patients With Grade I or II Essential Hypertension: Randomized, Double‐Blind, Placebo‐Controlled Study (2013) (24)
Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats. (2001) (23)
Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats (2007) (23)
[Calcium channel blocker]. (1998) (23)
Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients. (1997) (23)
The active molecular form of plasma adrenomedullin is extracted in the pulmonary circulation in patients with mitral stenosis: possible role of adrenomedullin in pulmonary hypertension. (2001) (22)
Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats. (2000) (22)
Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension (2003) (22)
Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial (2015) (22)
Association of smoking with aortic wave reflection and central systolic pressure and metabolic syndrome in normotensive Japanese men. (2009) (22)
Right atrial abnormalities in a patient with arrhythmogenic right ventricular cardiomyopathy without ventricular tachycardia. (2008) (21)
Vascular eicosanoid production in experimental hypertensive rats with different mechanisms. (1991) (21)
Variations of human adrenomedullin gene and its relation to cardiovascular diseases. (2003) (20)
Evidence for lack of a role of cGMP in effect of alpha-hANP on aldosterone inhibition. (1987) (20)
Effects of atrial natriuretic peptide on renal arterioles: morphometric analysis using microvascular casts. (1990) (20)
Role of the aldosterone system in the salt-sensitivity of patients with benign essential hypertension. (1983) (20)
Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR. (2000) (20)
Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension. (1996) (20)
Relationship between markers of inflammation and brachial-ankle pulse wave velocity in Japanese men. (2006) (19)
Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability (2014) (19)
Alterations of the cardiovascular and renal prostaglandins and thromboxanes system in prehypertensive spontaneously hypertensive rats. (1989) (19)
Effects of intracerebroventricular infusion of aldosterone on blood pressure and sodium and potassium concentrations in cerebral spinal fluid in rats. (1988) (19)
Idiopathic left innominate vein stenosis manifested following the creation of arteriovenous fistula in uremia. (1994) (19)
Rapid smooth muscle cell growth and endogenous prostaglandin system in spontaneously hypertensive rats. (1991) (19)
Successful erythropoietin treatment for severe anemia in nephrotic syndrome without renal dysfunction. (1996) (19)
Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism. (2004) (19)
Role of endothelium-derived relaxing factor in endothelin-induced renal vasoconstriction. (1991) (19)
Nicorandil but not ISDN Upregulates Endothelial Nitric Oxide Synthase Expression, Preventing Left Ventricular Remodeling and Degradation of Cardiac Function in Dahl Salt-sensitive Hypertensive Rats With Congestive Heart Failure (2006) (19)
The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes. (1997) (18)
Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin. (2002) (18)
Practitioner's Trial on the Efficacy of Antihypertensive Treatment in Elderly Patients with Hypertension II (PATE‐Hypertension II study) in Japan (2011) (18)
Effect of trichlormethiazide and captopril on nitric oxide synthase activity in the kidney of deoxycorticosterone acetate-salt hypertensive rats. (1996) (18)
Effects of Valsartan on the Progression of Chronic Renal Insufficiency in Patients with Nondiabetic Renal Diseases (2005) (18)
Magnesium ion: a possible physiological regulator of aldosterone production. (1989) (18)
Variations in arterioles in spontaneously hypertensive rats (1989) (18)
Acute and chronic effects of a hypocaloric diet on 24-hour blood pressure, heart rate and heart-rate variability in mildly-to-moderately obese patients with essential hypertension. (1999) (18)
Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension. (1988) (17)
Effects of smoking cessation or alcohol restriction on metabolic and fibrinolytic variables in Japanese men. (2002) (17)
OPC‐13340, a New Dihydropyridine Calcium Channel Blocker Attenuates Rapid Vascular Smooth Muscle Cell Growth in Spontaneously Hypertensive Rats (1992) (17)
Pretreatment plasma renin activity levels correlate with the blood pressure response to telmisartan in essential hypertension. (2008) (17)
Effect of alpha-human atrial natriuretic peptide on proteinuria in patients with primary glomerular diseases. (1989) (17)
Role of endogenous ANP in sodium excretion in rats with experimental pulmonary hypertension. (1992) (17)
Blood pressure, renal and endocrine responses to alpha-human atrial natriuretic polypeptide in healthy volunteers. (1986) (16)
Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats. (2001) (16)
Stimulating effects of atenolol on vasodepressor prostaglandin generation in spontaneously hypertensive rats. (1991) (16)
Plasma brain natriuretic peptide and N-terminal proatrial natriuretic peptide levels in obese patients: a cause or result of hypertension? (2004) (16)
Effects of alcohol intake on organ injuries in normotensive and hypertensive human subjects. (1997) (16)
Normalization of increased sodium sensitivity by maintenance hemodialysis. (1990) (16)
Effects of atrial natriuretic peptide on endothelin-induced vasoconstriction and intracellular calcium mobilization. (1991) (15)
Factitious proteinuria in a young girl. (1990) (15)
Guidelines for hypertension in the elderly--1999 revised version. Ministry of Health and Welfare of Japan. (1999) (15)
Combination Therapy With Telmisartan and Spironolactone Alleviates L-NAME Exacerbated Nephrosclerosis With an Increase in PPAR-γ and Decrease in TGF-β1 (2007) (15)
Plasma renin activity in hemodialyzed patients during long-term follow-up. (1995) (15)
Urinary excretions of albumin and type IV collagen in normotensive and hypertensive subjects. (2000) (15)
Microsatellite DNA polymorphism of human adrenomedullin gene in type 2 diabetic patients with renal failure. (2003) (14)
Expression of inducible nitric oxide synthase, left ventricular function and remodeling in Dahl salt-sensitive hypertensive rats. (2003) (14)
Response of adrenomedullin system to cytokine in cardiac fibroblasts-role of adrenomedullin as an antifibrotic factor. (2005) (14)
Pathophysiological role of endothelin in renal transplantation. (1991) (14)
Plasma concentrations of alpha-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease. (1987) (14)
Different secretion patterns of two molecular forms of cardiac adrenomedullin in pressure- and volume-overloaded human heart failure. (2004) (14)
Relation between cardiovascular complications and blood pressure/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study. (2009) (14)
Betaxolol stimulates eNOS production associated with LOX-1 and VEGF in Dahl salt-sensitive rats (2004) (14)
COMPARISON OF THE EFFECTS OF AMLODIPINE AND LOSARTAN ON 24-HOUR AMBULATORY BLOOD PRESSURE IN HYPERTENSIVE PATIENTS (2002) (14)
Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) (2011) (14)
Antiproteinuric Effect of Cilnidipine in Hypertensive Japanese Treated with Renin-Angiotensin-System Inhibitors - A Multicenter, Open, Randomized Trial Using 24-Hour Urine Collection (2010) (14)
A comparative study on the hemodynamic, renal and endocrine effects of alpha-human atrial natriuretic polypeptide in normotensive persons and patients with essential hypertension. (1986) (13)
Effects of atrial extract on blood pressure and urinary excretion of electrolytes and prostaglandin E2 in rats. (1984) (13)
Acute hemodynamic effects of alpha human atrial natriuretic polypeptide in patients with congestive heart failure. (1988) (13)
PLASMA ADENOSINE CONCENTRATIONS ARE ELEVATED IN CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RATS (1992) (13)
Responses of natriuretic peptides to acute and chronic salt loading in normotensive and hypertensive subjects. (1998) (13)
Aspirin renography to detect unilateral renovascular hypertension. (1994) (13)
Relationship between birth weight and cardiovascular risk factors in Japanese young adults (2000) (13)
Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension. (2009) (13)
Cardioprotective effect of benidipine on cardiac performance and remodeling in failing rat hearts. (2008) (12)
Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients. (2010) (12)
Relationship between the renin-aldosterone system and atrial natriuretic polypeptide in rats. (1987) (12)
Molecular forms of adrenomedullin in pericardial fluid and plasma in patients with ischaemic heart disease. (2002) (12)
Protective role of renal nerves in the development of diabetic nephropathy. (1993) (12)
Effect of natrium ionophore on aldosterone production in the rat adrenal gland. (1984) (12)
Year-long antihypertensive therapy with candesartan completely prevents development of cardiovascular organ injuries in spontaneously hypertensive rats. (2010) (12)
Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats. (2001) (12)
[Implications of obesity for target organ injuries and cardiovascular risk factors in hypertensive subjects]. (1997) (11)
Renal effects of atrial natriuretic peptide during dopamine infusion. (1990) (11)
Mechanisms of the Natriuretic Effects of Neutral Endopeptidase Inhibition in Dahl Salt‐Sensitive and Salt‐Resistant Rats (1994) (11)
Antiproliferative effects of the serotonin type 2 receptor antagonist, ketanserin, on smooth muscle cell growth in rats. (1991) (11)
Characterization of atrial natriuretic peptide in urine from rats treated with a neutral endopeptidase inhibitor. (1992) (11)
Insertion/deletion angiotensin converting enzyme gene polymorphism affects the microvascular structure of the kidney in patients with nondiabetic renal disease. (1999) (11)
Do commercially available assay kits for B-type natriuretic peptide measure Pro-BNP1-108, as well as BNP1-32? (2007) (11)
Predictive Significance of Blood Pressure Values for the Incidence of Cardiovascular Events in Chronic Hemodialysis Patients (2008) (11)
Chromosomal sublocalization and microsatellite DNA polymorphism of human adrenomedullin gene (2001) (11)
Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease (2011) (11)
Long-term efficacy of combination therapy with losartan and low-dose hydrochlorothiazide in patients with uncontrolled hypertension. (2007) (10)
Morphometric analysis of arteriolar diameters in experimental nephropathies: Application of microvascular casts (2005) (10)
Delayed Pericarditis Associated with an Implantable Cardioverter Defibrillator Implantation Using an Active‐Fixation Atrial Lead (2008) (10)
A biphasic effect of noradrenaline on renin release from rat juxtaglomerular cells in vitro is mediated by α1- and β-adrenoceptors (1992) (10)
Non‐invasive Monitoring of Hemodynamic Changes During Hemodialysis by the Use of a Newly Developed Admittance Cardiograph (2005) (10)
Effects of chronic administration of atrial natriuretic polypeptide on glomerular lesions in spontaneously hypertensive rats. (1990) (10)
Lower Birth Weight Is Associated with Higher Resting Heart Rate during Boyhood (2007) (10)
Estimation of the secretion rate of atrial natriuretic peptide from the coronary sinus in coronary artery disease. (1988) (10)
Patient-hospital relationship and quality of life in elderly patients with hypertension. (1995) (10)
Morphometric analysis of renal arterioles in subtotally nephrectomized rats. (1993) (9)
Short-term increase in prostaglandin I2 synthesis caused by cicletanine in patients with essential hypertension. (1995) (9)
Variations in renal arteriolar diameter in deoxycorticosterone acetate-salt hypertensive rats (1990) (9)
Questionnaire survey on the Japanese guidelines for treatment of hypertension in the elderly: 1999 revised version. (2002) (9)
Effects of a Japanese medicinal plant on the rat subtotal nephrectomy model: evaluation of its effect by microvascular casts. (1990) (9)
Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients (2009) (9)
Effects of magnesium on changes in blood pressure and plasma aldosterone induced by angiotensin II. (1990) (9)
Alterations of calcium channels in vascular smooth muscle cells from spontaneously hypertensive rats. (1992) (9)
Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1). (2007) (8)
[Effects of intravascular contrast media on urinary excretion of liver fatty acid-binding protein]. (2005) (8)
Two molecular forms of plasma adrenomedullin during tilt test in healthy subjects (2001) (8)
Risk factors for progression of diabetic nephropathy. (1995) (8)
The haemodynamic, renal and endocrine effects of alpha-human atrial natriuretic polypeptide in normotensive people and patients with essential hypertension. (1986) (8)
Benazepril slows progression of renal dysfunction in patients with non‐diabetic renal disease (2007) (8)
[Therapeutic policy for elderly hypertensives in Japan--a questionnaire survey of specialists]. (1994) (8)
Implantable cardioverter defibrillator in maintenance hemodialysis patients with ventricular tachyarrhythmias: A single‐center experience (2009) (8)
Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial (2016) (7)
A Possible Physiological Role of Atrial Natriuretic Peptide in Body Fluid Volume Regulation (1988) (7)
Source of plasma adrenomedullin in patients with pheochromocytoma. (2002) (7)
Renoprotective effect of long-term combined treatment with adrenomedullin and omapatrilat in hypertensive rats (2005) (7)
Differential effects of atrial natriuretic peptide and dopamine on urinary protein excretion in chronic glomerulonephritis. (1991) (7)
Silent lupus nephritis with fingerprint deposits. (1993) (7)
Changes in heart rate variability before and after surgery in patients with pheochromocytoma (2004) (7)
[Estimation of the intrarenal hemodynamics in patients with primary aldosteronism]. (1989) (7)
Up-regulated synthesis of mature-type adrenomedullin in coronary circulation immediately after reperfusion in patients with anterior acute myocardial infarction (2005) (7)
Alteration of renal adrenomedullin and its receptor system in the severely hypertensive rat: effect of diuretic (2005) (7)
Plasma concentration of atrial natriuretic polypeptide in patients with atrial tachycardia. (1987) (7)
Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR. (2002) (7)
[Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)]. (2008) (7)
Possible role of adrenomedullin in the regulation of Fontan circulation: Mature form of plasma adrenomedullin is extracted in the lung in patients with Fontan procedure (2007) (6)
Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure. (2004) (6)
Clinical Efficacy of a New Angiotensin II Type 1 Receptor Blocker, Pratosartan, in Hypertensive Patients (2008) (6)
Upregulation of intracardiac adrenomedullin and its receptor system in rats with volume overload-induced cardiac hypertrophy (2005) (6)
Effects of manidipine and delapril on glucose and lipid metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus. (1992) (6)
Chronic effect of combined treatment with omapatrilat and adrenomedullin on the progression of heart failure in rats. (2006) (6)
Left ventricular systolic and diastolic function and mass before and after antihypertensive treatment in patients with essential hypertension. (1997) (6)
Chronic Effects of Intracerebroventricular Endothelin-1 on Blood Pressure and Water and Sodium Handling in the Rat. (1994) (6)
Rationale for time-qualified reference standards for 24-hour blood pressure values and their circadian rhythms in Japanese normotensive adults: a study by the Ambulatory Blood Pressure Monitoring Research Group. (1999) (6)
[Suppressive effect of nicorandil in ventricular arrhythmias after reperfusion therapy in patients with acute myocardial infarction]. (2007) (6)
The Deletion Allele of Angiotensin-Converting Enzyme Gene Polymorphism as a Cardiovascular Risk Factor in Patients Undergoing Long-Term Hemodialysis (2000) (6)
Force-length relationship in dogs as a measure of protective effect of imidapril on regional myocardial ischemia and reperfusion injury. (2000) (6)
The effect of angiotensin-converting enzyme inhibition on regional blood flow in salt-depleted and salt-loaded normotensive conscious rats. (1979) (5)
[A case of pseudo-Bartter's syndrome induced by long-term ingestion of furosemide delivered orally through health tea]. (2003) (5)
Junichi Minami , Toshihiko Ishimitsu and Hiroaki Matsuoka Smokers Effects of Smoking Cessation on Blood Pressure and Heart Rate Variability in Habitual (1999) (5)
Evidence for Medial‐Mass Regression in the Vascular Wall of Dahl Hypertensive Rats by Cicletanine Treatment (1991) (5)
Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension (2009) (5)
Is it time to regad cigarette smoking as a risk factor in the development of sustained hypertension? (1999) (5)
[Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm and sustained ventricular tachycardia: a case report]. (2001) (5)
A biphasic effect of noradrenaline on renin release from rat juxtaglomerular cells in vitro is mediated by alpha 1- and beta-adrenoceptors. (1992) (5)
Molecular forms of adrenomedullin in pericardial fluid and plasma in patients with ischaemic heart disease (2002) (5)
Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats. (2006) (5)
Effects of beta-lipotropin on aldosterone production in rats. (1980) (5)
Blood pressure and other risk factors before the onset of myocardial infarction in hypertensive patients (1998) (5)
[Effect of hemodialysis on peak velocity of early diastolic mitral annulus motion]. (2004) (4)
Betaxolol inhibits extracellular signal-regulated kinase and P70S6 kinase activities and gene expressions of platelet-derived growth factor A-chain and transforming growth factor-beta1 in Dahl salt-sensitive hypertensive rats. (2002) (4)
IN VIVO AND IN VITRO EFFECTS OF ATRIAL NATRIURETIC PEPTIDE ON RENIN RELEASE (1992) (4)
[STONE study and INSIGHT study: efficacy of nifedipine in the prevention of cardiovascular disease in hypertensive patients]. (2006) (4)
Effects of human atrial 28-amino-acid peptide on renal production of prostaglandin E2 in rats. (1985) (4)
Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats. (2002) (4)
Immunohistochemical study of vascular lesions in severe hypertension induced by DOCA and salt administration to spontaneously hypertensive rats. (1990) (4)
Effects of dietary salt and angiotensin-converting enzyme inhibitor on ATP-driven Ca pump and Na/Ca exchange in aortic rings of Dahl rats. (1996) (4)
Effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) on the main regulatory mechanisms for blood pressure and body fluid volume in rats. (1985) (4)
Interaction between sympathetic nerve activity and atrial natriuretic peptide with respect to the effects on renal hemodynamics in patients with cardiovascular diseases. (1989) (4)
Effects of high salt intake on hemodynamic responses to isometric exercise in normotensive subjects and in patients with essential hypertension. (1983) (4)
Two Molecular Forms of Adrenomedullin in Congenital Heart Disease (2003) (4)
Are plasma levels of atrial natriuretic peptide, N-terminal ProANP, and brain natriuretic peptide affected by the presence of coronary artery disease? (2004) (3)
Abnormal response of urinary eicosanoid system to norepinephrine infusion in patients with essential hypertension. (1992) (3)
Long‐Term Antihypertensive Effects of Aliskiren, a Direct Renin Inhibitor, in Chronic Hemodialysis Patients (2013) (3)
Myocardial contractility of the canine left ventricle during unsynchronized dual chamber pacing. (1997) (3)
Changes in plasma endothelin-1 concentration during blood volume depletion and expansion: role of the cardiopulmonary baroreflex. (1995) (3)
Plasma brain natriuretic peptide levels indicate the distance from decompensated heart failure. (2004) (3)
The effects of atrial pacing and ballooning on the plasma concentration of atrial natriuretic peptide in anesthetized dogs with or without vagotomy. (1987) (3)
Renal and hormonal effects of alpha1-adrenoceptor blockade by bunazosin in essential hypertension (2004) (3)
Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects? (2008) (3)
[Long-term antihypertensive treatment (GLANT Study)]. (1995) (3)
RENAL AND ENDOCRINE EFFECTS OF URAPIDIL IN PATIENTS WITH ESSENTIAL HYPERTENSION (1991) (3)
Plasma concentration of alpha-hANP and renal responses to alpha-hANP infusion in patients with congestive heart failure and those with chronic renal failure. (1988) (3)
Relation of CYP11B2 Gene Polymorphism to the Incidence of Cardiovascular Diseases in Chronic Hemodialysis Patients (2003) (3)
Effect of cilazapril and salt on Ca2+ extrusion in arterial smooth muscle of Dahl rats. (1997) (3)
Recent Progress in the Treatment of Diseases in the Elderly (1996) (3)
[Aldosterone and magnesium]. (2005) (3)
[Guidelines on treatment of hypertension in the elderly--1999 revised version. A comprehensive study on geriatric science by the Ministry of Health and Welfare. A Section for the "Study on Long-Term Prognosis of Hypertension among the Aged"]. (1999) (3)
[Beneficial effects of combination therapy with losartan and low-dose hydrochlorothiazide in the treatment of essential hypertension]. (2005) (2)
Comparison of first-line antihypertensive drugs by a randomized cross-over method--a preliminary report. (1995) (2)
Diurnal Variation of Blood Pressure in Patients with Salt Sensitive Hypertension (1993) (2)
[Large clinical trials of ARB in Japan and its reflection to new guidelines]. (2009) (2)
Effects of renal dysfunction on cardiovascular events in diabetic patients with hypertension: Challenge-DM Study subgroup analysis (2011) (2)
Effects of atrial natriuretic peptide on urinary protein excretion in mesangial proliferative glomerulonephritis. (1991) (2)
[Multicenter prospective survey of prognosis of hypertensive elderly outpatient under antihypertensive treatment--morbidity and mortality of cardiovascular diseases and cancer]. (1999) (2)
Factors participating in blood pressure elevation after discharge from the hospital in patients with essential hypertension. (1990) (2)
Progressive Renal Failure inPOEMS Syndrome (1998) (2)
ATRIAL NATRIURETIC PEPTIDE INHIBITS THE ALDOSTERONE RESPONSE TO METOCLOPRAMIDE IN PATIENTS WITH GLOMERULAR DISEASE AND ESSENTIAL HYPERTENSION (1991) (2)
Can large-scale trials or meta-analyses demonstrate blood pressure--independent effect of angiotensin receptor blockers? (2007) (2)
Quantitative Estimation of Ideal Body Weight in Uremic Patients (1995) (2)
Importance of Blood Pressure Reduction to Protect Organ Damage (2003) (2)
Effects of beta-lipotropin and beta-lipotropin-derived peptides on aldosterone production in the rat adrenal gland. (1981) (2)
Design and Rationale of the Study of Assessment for Kidney Function by Urinary Microalbumin in Randomized (SAKURA) Trial (2011) (2)
Hemodynamic, Renal, and Endocrine Responses to α-hANP in Normotensive Persons and Patients with Essential Hypertension (1986) (2)
[Evaluation by specialists of the Guidelines on Treatment of Hypertension in the Elderly--the second questionnaire survey]. (1997) (2)
Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin (2014) (2)
Letters Regarding Article by Bibbons-Domingo et al, “B-Type Natriuretic Peptide and Ischemia in Patients With Stable Coronary Disease: Data From the Heart and Soul Study” (2005) (1)
Altered phospholipase C activity in renal medulla of DOCA-salt hypertensive rats. (1991) (1)
[Long-term beneficial effect of dual chamber pacing in a patient with hypertrophic obstructive cardiomyopathy]. (1997) (1)
Effects of Dietary Salt on Inhibition of Norepinephrine- Induced Contraction by Ryanodine and Verapamil in Isolated Aortic Rings from Dahl Rats (1994) (1)
Cardiovascular and renal effects of the converting enzyme inhibitor ramipril in patients with essential hypertension (1989) (1)
[Patient-hospital relationship and quality of life in elderly patients with hypertension]. (1994) (1)
Effects of alpha human atrial natriuretic polypeptide on the systemic hemodynamics and coronary circulation in patients with ischemic heart disease. (1988) (1)
Clinical Significance of Post-Dialysis Plasma Concentrations of Atrial Natriuretic Peptide and Brain Natiuretic Peptide as Long-term Survival Predictors in Hemodialysis Patients : 15-year follow up study (2008) (1)
[Interaction between angiotensin II and other local vasoactive substances]. (1999) (1)
Alternans of ventricular gradient during percutaneous transluminal coronary angioplasty. (2001) (1)
[Treatment of elderly hypertension based on various hypertension management guidelines--comparison between European and American guidelines and Japanese guidelines]. (2005) (1)
[A case of congenital nephrogenic diabetes insipidus accompanied by hypertension]. (2001) (1)
Influence of appendectomy by maze procedure on the atrial natriuretic peptide (ANP) secretion and body fluid retention (1996) (1)
4 On-going Japanese Clinical Trials for Hypertension II : Seeking for More Effective Pharmacological Treatment(ESC-JCS Joint Symposium (ESC-JCS Joint Symposium) (H) Evidence-Based Medical Treatment of Hypertension,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society (2008) (1)
Role of adenosine A1 and A2 receptors in the regulation of aldosterone production in rat adrenal glands (1990) (1)
P-38: Effect of periphral vessel congestion on diastolic blood pressure measurements with auscultatory method (2001) (1)
Relation between the initial portion of the signal-averaged QRS complex and cardiac function and infarct size in patients with myocardial infarction. (1997) (1)
[Circulatory vasoactive substances and pathophysiology of hypertension]. (2006) (1)
Clinical importance of late potential in patients with angina pectoris. (1997) (1)
543 COMPRISON OF THE ANTIALBUMINURIC EFFECTS BETWEEN L-/N-TYPE AND L-TYPE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH DIABETES AND MICROALBUMINURIA: THE STUDY OF ASSESSMENT FOR KIDNEY FUNCTION BY URINARY MICROALBUMIN IN RANDOMIZED (SAKURA) TRIAL (2012) (1)
PJ-392 Effect of Combination Therapy with Bone-Marrow Mononuclear Cells Implantation and Sarpogrelate Hydrochloride on Angiogenesis and Cardiac Performance in Myocardial Ischemia(PJ066,ACS/AMI (Basic) (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Soci (2009) (0)
Subject Index Vol. 15, 1995 (1995) (0)
D070: Prognosis of elderly hypertensive patients in Japan (1999) (0)
Effect of percutaneous coronary rotational atherectomy on precordial QT dispersion (2001) (0)
PROTECTIVE EFFECTS OF ANGIOTENSIN-II RECEPTOR BLOCKER AND LONG-ACTING CA ANTAGONIST AGAINST CARDIOVASCULAR ORGAN INJURIES IN HYPERTENSIVE PATIENTS: P 720 (2004) (0)
Efficacy of percutaneous transluminal coronary angioplasty in chronic hemodialysis patients: our second report. (1993) (0)
Celiprolol Activates eNOS Activity through PI3 Kinase-Akt Signaling Pathway and Inhibits VCAM-1 and NF-κ B Induced by Oxidative Stress (2003) (0)
Effects of Intravenous Administration of Adrenomedullin (AM) in Patients with Acute Heart Failure (2007) (0)
Improved Contractile Dysfunction and Altered SERCA2 Expression in Treatment with Probucol in Dahl Salt-Sensitive Hypertensive Heart Failure (2003) (0)
Nephrogenous cyclic GMP production during NaCl loading and ANP infusion. (1990) (0)
VALSARTAN RETARDS PROGRESSION OF RENAL FAILURE INDEPENDENTLY OF HYPOTENSIVE EFFECT IN PATIENTS WITH NONDIABETIC RENAL DISEASES: OP 162 (2004) (0)
Effect of long-term treatment of selective vasopressin antagonist on the development of heart failure in rats (1994) (0)
-273-ENHANCED INHIBITORY EFFECT OF AN I.V.BOLUS OF 1-SAR,8-ILE-ANGIOTENSIN II ON THE PRESSOR RESPONSE TO ANGIOTENSIN II IN PATIENTS WITH ESSENTIAL HYPERTENSION : Renin,Angiotensin : PROCEEDINGS OF THE 42nd ANNUAL MEETING OF THE JAPANESE CIRCULATION SOCIETY (1978) (0)
-0550-EFFECTS OF ENDOTHELIUM-DERIVED FACTORS ON PRESSURE-NATRIURESIS IN SPONTANEOUSLY HYPERTENSIVE RATS (SHR) (1990) (0)
Screening for Ischemic Heart Disease by the Index of Ventricular Gradient Variability (2003) (0)
Cardioprotective Mechanisms of Combination Therapy with Selective Aldosterone Blocker and ARB Associated with JAK-STAT Pathway in Failing Rat Hearts(Atherosclerosis, Basic 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
PJ-176 Eplerenone Stimulates eNOS Through VEGF and Inhibiting iNOS via NF-κB Induced by the Oxidative Stress-LOX-1 Pathway(Hypertension, Basic 2 (H) : PJ30)(Poster Session (Japanese)) (2004) (0)
Plasma atrial natriuretic peptide, brain natriuretic peptide, and adrenomedullin in pacemaker implanted patients (1998) (0)
Cardiorenoprotective Effect of Fasudil, a Specific Rho-kinase Inhibitor, in Malignant Hypertensive Rat(Kidney/Renal Circulation 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
PE-288 High-sensitivity C-reactive Protein Could Reflect Coronary Atherosclerosis in the Ischemic Heart Disease(Chronic coronary heart disease/Remodeling(02)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
Molecular Forms of BNP and ANP and gene expression of processing enzyme in atrium and ventricle in heart failure rat (2008) (0)
Present Status of Blood Pressure Control in a Group of Hypertensive Patients Followed-up in a Cardiovascular Outpatient Clinic (2004) (0)
[Changes in systemic hemodynamics and plasma catecholamine concentrations during isometric exercise in patients with essential hypertension]. (1985) (0)
Diversity of Molecular Forms of Plasma Brain Natriuretic Peptide (BNP) in Patients with Heart Failure (HF) (2008) (0)
Erratum: The combination of hypertension to prevent cardiovascular events (COPE) trial: Rationale and design (Hypertension Research (2005) vol. 28 (331-338)) (2006) (0)
Differential Effect to the Cardiac Endothelial Nitric Oxide Synthase Expression in Dahl Salt-Sensitive Hypertensive Heart Failure : Nicoandil versus Isosorbide Dinitrate (2003) (0)
LONG-TERM ANTIHYPERTENSIVE TREATMENT OF ESSENTIAL HYPERTENSION. OBSERVATIONS ON PATIENTS WHO WERE TREATED FOR MORE THAN TEN YEARS : SYMPOSIUM III : Diagnosis and Treatment (1977) (0)
0888 EFFECTS OF ANTIHYPERTENSIVE DRUGS ON NITRIC OXIDE SYNTHASE AND MICROVASCULAR REMODELING IN DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSIVE RATS (1997) (0)
MPS 03-08 ON-TREATMENT BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN OLDER ADULTS WITH ISOLATED SYSTOLIC HYPERTENSION: VALSARTAN IN ELDERLY ISOLATED SYSTOLIC HYPERTENSION (VALISH) STUDY (2016) (0)
P-6: Effects of alcohol intake on ambulatory blood pressure and heart rate in Japanese men with different ALDH2 genotypes (2001) (0)
[Effect of caffeine and other drinks containing caffeine on blood pressure]. (2000) (0)
[Hypertension and vitamin]. (2000) (0)
Corn parison of First-Line Antihypertensive a Randomized Cross-Over Method -A Preliminary Report- (2006) (0)
[Combination of ACEI and ARB therapy for heart failure]. (2007) (0)
-347-RENAL EFFECTS OF ATRIAL NATRIURETIC PEPTIDE DURING DOPAMINE INFUSION : Atrial Natriuretic Polypeptide : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1989) (0)
An immunohistochemical study of renal vascular lesions in hypertensive patients. (1985) (0)
Stimulation of aldosterone production by beta-melanotropin. (1981) (0)
OJ-530 Eplerenone Shows Renoprotective Effect by Reducing LOX-1-Mediated Adhesion Molecule Expression and PKC ε-ERK1/2-p90RSK Pathway Activation(Kidney/Renal Circulation 3 (H) : OJ65)(Oral Presentation (Japanese)) (2004) (0)
[The effects of atrial natriuretic peptide on urinary protein excretion in patients with renal parenchymal disease and those with diabetic mellitus]. (1990) (0)
[Diurnal variation of blood pressure in salt-responder]. (1992) (0)
A case of ventricular tachycardia induced by antiarrhythmic drugs during hemodialysis. (1993) (0)
Prognostic Role of Plasma B-type Natriuretic Peptide Level (BNP) Levels in Patients with Chronic Stable Cardiovascular Disease (2005) (0)
1019 LONG-TERM ANTIHYPERTENSIVE EFFECTS OF ALISKIREN, A DIRECT RENIN INHIBITOR, IN CHRONIC HEMODIALYSIS PATIENTS (2012) (0)
Contents, Vol. 15, 1995 (1995) (0)
The role of the arachidonic acid cascade in the hypotensive activity of N-(dibenzyloxyphosphinoyl)-L-alanyl-L-prolyl-L-proline (1986) (0)
PE-380 Cardio Ankle Vascular Index (CAVI) is Useful Index for Evaluating Coronary Risk(Atherosclerosis, clinical(07)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
Outcome of CAPD in patients with severe heart disease and end-stage renal failure (1994) (0)
Guidelines for Hypertension in the 1999 Revised Version-Elderly (2006) (0)
Effects of f3-Lipotropin and ,-Lipotropin-derived Peptides on Aldosterone Production in the Rat Adrenal Gland (2013) (0)
Abstract 2561: Plasma Adrenomedullin Level is a Long-Term Prognostic Marker in Patients with Chronic Stable Cardiovascular Disease (2006) (0)
[The effects of ketanserin on vascular eicosanoid system in spontaneously hypertensive rats and their implications]. (1989) (0)
Effect of Combination Therapy with Bone-marrow Mononuclear Cell Implantation and Eplerenone on Angiogenesis and Cardiac Performance in Myocardial Ischemia (2007) (0)
[Changes in practice guidelines for hypertension therapy]. (2006) (0)
PJ-116 Cardioprotective Effect of Tetrahydrobiopterin via Inhibiting Oxidative Stress in Failing Rat Hearts(Heart failure, basic(05)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
1 Low-dose Diuretics Are the Treatment of First Choice for Patients with Uncomplicated Hypertension in Japan(Controversy 5 (C5) (H) : Hypertension)(Special Program) (2004) (0)
[Effects of an angiotensin II antagonist on systemic hemodynamics and renal functions in various forms of hypertension (author's transl)]. (1979) (0)
LONG-TERM EFFECTS OF CANDESARTAN AND AMLODIPINE ON CARDIOVASCULAR EVENTS IN HIGH-RISK HYPERTENSIVE PATIENTS: RESULTS OF CASE-J EXTENSION: HT.2.04 (2010) (0)
A Selective COX-2 Inhibitor Ameliorates Cardiac Dysfunction and Cardiovascular Remodeling in Failing Heart of Dahl Salt-Sensitive Rats (2003) (0)
secondary hypertension Hormonal and renal effects of atrial natriuretic peptide in patients with (2011) (0)
Diagnostic Process for Left Ventricular Diverticulum(Author's Reply) (2004) (0)
Effect of Candesartan on Left Ventricular Systolic Function along the Long Axis in Patients with Essential Hypertension (2003) (0)
Cardioprotective Effect of Combination Therapy with ARB and Statin in Failing Heart of Dahl Salt-sensitive Rats (2005) (0)
Additions and Corrections (2006) (0)
OJ-008 Response of adrenomedullin system to cytokine stimulation in rat cardiac fibroblasts : Role of adrenomedullin as an autocrine factor(Neurohumoral Factors 1 (H) : OJ2)(Oral Presentation (Japanese)) (2004) (0)
A COMPARISON OF THE EFFECTS OF BETA BLOCKING AGENTS ON PLASMA RENIN ACTIVITY, RENIN SUBSTRATE, AND RENAL RENIN CONTENT IN RATS (1975) (0)
Molecular Form of Plasma Brain Natriuretic Peptide in Heart Failure: Different proBNP-108 to BNP-32 Ratios in Atrial and Ventricular Overload (2009) (0)
Correlation between congnitive and motor function in elderly patients with hypertension (1993) (0)
OJ-161 Smoking Habits Deteriorate Arterial Compliance and Increase Central Blood Pressure despite a Similar Effect on Brachial Blood Pressure(Smoking(H),Oral Presentation (Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
EFFECTS OF DIETARY SALT AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ON Na/Ca EXCHANGE AND ATPDRIVEN Ca PUMP IN AORTIC RINGS OF DAHL RATS (1994) (0)
PE-279 Carvedilol in Idophasic Dilated Cardiomyopathy : is It Possible to Identify Factors Predictive of Improvement of LVEF?(Cardiomyopathy, basic/clinical(04)(M),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
Two Molecular Forms of Adrenomedullin (AM) in Pericardial Fluids are Increased in Patients with Valvular Heart Disease (2002) (0)
Effect of Combination Therapy with bFGF and G-CSF on Angiogenesis and Cardiac Function in Myocardial Ischemia (2007) (0)
Bradykinin Ameliorates Cardiac Performance and Remodeling under Ca-Antagonist Treatment in Failing Rat Hearts (2003) (0)
Left ventricular systolic and diastolic function along the long axis before and after antihypertensive treatment in patients with essential hypertension (2002) (0)
The Relationship Between Cardiac Gene Expression and Cardiac Systolic and Diastolic Function in Transition of Cardiac Hypertrophy to Heart Failure (2005) (0)
2 New Japanese evidence of hypertension and their reflection in new guideline(ESC-JCS Joint Symposium (ESC-JCS Joint Symposium) (H) Evidence-Based Medical Treatment of Hypertension,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
EFFECTS OF ACE INHIBITOR AND ANGIOTENSIN-II RECEPTOR BLOCKER ON LEFT VENTRICULAR MASS IN CHRONIC HEMODIALYSIS PATIENTS: OP 035 (2004) (0)
Effect of combination therapy with sustained-release bFGF and G-CSF on angingenesis and cardiac function in myocardial ischemia (2008) (0)
Renoprotective effect of p38 mitogen-activated protein kinase inhibitor in salt-sensitive hypertensive rat (2003) (0)
A typical highest thoracic artery (A. thoracica suprema)-a case report (2001) (0)
Involvement of Rho-kinase pathway for angiotensin II-induced PAI-1 gene expression and cardiovascular remodeling in hypertensive rats (2002) (0)
2-hour Postchallenge Blood Glucose was More Closely Related to Brachial-ankle Pulse Wave Velocity than Fasting Blood Glucose in Japanese Men (Diabetes/Obesity 6 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
[Smoking habits as a risk factor in the development of hypertensive organ damage]. (2004) (0)
OJ-418 Roles of Bradykinin-NO Pathway and Oxidative Stress for Cardiac Remodeling in Failing Rat Hearts and Cardioprotective Mechanism of Benidipine(Endothelium/NO 5 (H) : OJ51)(Oral Presentation (Japanese)) (2004) (0)
OJ-419 Pitavastatin Improves Cardiac Function and Remodeling via Activation of eNOS and Reduction of Oxidative Stress in Failing Rat Hearts(Endothelium/NO 5 (H) : OJ51)(Oral Presentation (Japanese)) (2004) (0)
Therapeutic Application of Adrenomedullin (2005) (0)
[Large clinical intervention trial meta-analysis]. (2000) (0)
Kidney Function as a Predictor for Long-term Mortality in Patients with Stable Chronic Cardiovascular Disease (2005) (0)
ENHANCEMENT OF VOLTAGE SENSITIVE CALCIUM CHANNEL ACTIVITY IN SPONTANEOUSLY HYPERTENSIVE RATS : Hypertension : 53 Annual Scientific Meeting, Japanese Circulation Society (1989) (0)
Malignant Hypertensive Rats Long-Term Administration of Rho-Kinase Inhibitor Ameliorates Renal Damage in (2006) (0)
PE-466 Clinical Usefulness of a Newly Developed Instrument for Non-invasive Monitoring of Beat-by-beat Cardiovascular Hemodynamic Parameters(Cardiac Function, Basic/Clinical 3 (M) : PE79)(Poster Session (English)) (2004) (0)
FRS-080 Effects of Nicorandil on Cardiovascular Events in Patients with Coronary Artery Disease from the Japanese Coronary Artery Disease (JCAD) Study(FRS17,Novel Approaches to Treatment of CAD (IHD),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation S (2009) (0)
-0515-EFFECTS OF ANTIHYPERTENSIVE THERAPIES ON RENAL ARTERIOLAR DIAMETERS IN DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSIVE RATS : A MICROVASCULAR CAST STUDY (1990) (0)
[Pharmacological characteristics and choice of antihypertensives]. (2001) (0)
Plasma adrenomedullin in patients with cardiovascular diseases (1994) (0)
Background of Patients in the Four Groups Hypertension Renal Primary parenchymal Renovascular Characteristics aldosteronism hypertension hypertension (2005) (0)
Increased bnp level is associated with “pseudonormal” transmitral flow pattern (1998) (0)
Plasma Adrenomedullin Levels, but not BNP Levels, Correlate Long-Term Mortality and Cardiovascular Outcomes in Hypertensive Patients (2006) (0)
Effects of Combination Therapy with Selective Aldosterone Blocker and ARB on Cardiac Performance and Remodeling in Failing Rat Hearts (2005) (0)
PE-251 Ventricular Gradient Variability is Useful Index for Detecting the Presence of Ischemic Heart Disease(ECG/Body surface potential mapping/Holter-5 (A) PE42,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
[Interactions between anti-hypertensive and non-antihypertensive drugs]. (1992) (0)
A 55-year-woman Presenting at Addmission with the Chief Complaint of Macroscopic Hematuria (2009) (0)
Incidence of cardiovascular diseases and angiotensin-converting enzyme gene polymorphism in chronic hemodialysis patients (2001) (0)
[Clinical application of ARB and ACEI]. (2002) (0)
Evaluation of Atrial Natriuretic Peptide, Brain Natriuretic Peptide and N-Terminal Atrial Natriuretic Peptide in Patients with Permanent Pacemaker (2003) (0)
Detection of Atrial Tachyarrhythmia Using Plasma N-Terminal Pro-Atrial Natriuretic Peptide (N-ANP) in Patients without Demonstrable Heart Disease (2003) (0)
Polymorphism of the angiotensin-converting enzyme gene and the prognosis of chronic hemodialysis patients (1999) (0)
G-CSF Stimulates eNOS Production and Improves Cardiac Function and Angiogenesis in Myocardial Ischemia (Acute Myocardial Infarction, Basic 5 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
[Angiotensin type 1 receptor blocker reduced proteinuria in patients of focal glomerular sclerosis]. (2004) (0)
Valsartan reduced cardiac fibrosis by caspase-3 activation and TGF-β reduction in L-NAME/SHR in vivo (2002) (0)
A case of idiopathic left ventricular tachycardia associated with hemodialysis (2001) (0)
OJ-181 Oral Nicorandil Treatment after Acute Myocardial Infarction Improved Clinical Outcome in the Japanese Coronary Artery Disease (JCAD) Study(OJ31,ACS/AMI (Clinical/Treatment) (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
PE-417 Level of Kidney Function as a Predictor for Mortality in Patients with Stable Chronic Cardiovascular Disease : Long-term Follow-up Study(Kidney/Renal circulation-2 (H) PE70,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
[Combination therapy of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers]. (2005) (0)
-0556-ENDOGENOUS THROMBOXANE INHIBITORS AND VASCULAR SMOOTH MUSCLE CELL GROWTH OF RATS (1990) (0)
The hemodynamic renal and endocrine effects of alpha-human atrial natriuretic polypeptide in patients with primary glomerular diseases (1989) (0)
JAPANESE TRIAL ON THE EFFICACY OF ANTIHYPERTENSIVE TREATMENT IN THE ELDERLY II (JATE II): PRINCIPAL RESULTS (2004) (0)
Dopamine and aldosterone in adrenal glomerulosa cells in spontaneously hypertensive rats (1988) (0)
Diagnostic value of plasma ANP, N-ANP and BNP in patients with coronary artery disease (CAD) and normal left ventricular function (2002) (0)
Abstract 5075: Beneficial Effects of Combination of ACE Inhibitor and Rho-kinase Inhibitor on Tubulointerstitial Fibrosis Induced by Unilateral Ureteral Obstruction (2009) (0)
Abstract 1105: Fasudil, a Rho-Kinase Inhibitor, Reverses but not Prevents the L-NAME-Exacerbated Severe Nephrosclerosis in Spontaneous Hypertensive Rats (SHR) (2006) (0)
Immunohistochemical localization of physiologic urinary proteins in Wistar rats. (1991) (0)
OJ-248 Losartan Reduced Massive Proteinuria in Chronic Renal Disease Patients with Lower Renal Tissue TGF-beta1 mRNA Levels(Hypertension, Clinical 5 (H) : OJ29)(Oral Presentation (Japanese)) (2004) (0)
[Hypertensive organ injuries in spontaneously hypertensive rats given N(G)-nitro-L-arginine methyl ester]. (2006) (0)
Origin, diagnosis and treatment of circulatory diseases. Recent approaches. II. Hypertension. 2. Methods for individual treatment of hypertension. (1999) (0)
-0516-RELATION BETWEEN RENAL ARTERIOLAR DIAMETERS AND GLOMERULAR SCLEROSIS : DIFFERENCES BETWEEN OUTER AND INNER CORTEXES (1990) (0)
[Antihypertensive effect in elderly patients with hypertension--results of trials in foreign countries and Japanese situations]. (1994) (0)
[Status of mild hypertension guidelines in Japan and abroad]. (2008) (0)
FRS-029 Intravenous Administration of Adrenomedullin (AM) is Effective in Acute Heart Failure as a Therapeutic Drug(Clinical Heart Failure-Pathophysiology and Treatment, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Discrepancy between renal prostaglandins I2 and E2 in unilateral renovascular hypertension (1994) (0)
Involvement of TAK1-Smad-p38 MARK Signaling Pathway for Cardiovascular Remodeling in DOCA-Salt Hypertensive Rats (2003) (0)
[Acute and chronic effects of smoking on blood pressure]. (2000) (0)
OJ-133 Brachial Ankle Pulse Wave Velocity versus Cardio Ankle Vascular Index as a Predictor of the Presence of Coronary Artery Disease(Atherosclerosis, clinical-4 (H) OJ23,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hiroaki Matsuoka?

Hiroaki Matsuoka is affiliated with the following schools: